Detalles de la búsqueda
1.
Administering selected subscales of patient-reported outcome questionnaires to reduce patient burden and increase relevance: a position statement on a modular approach.
Qual Life Res
; 33(4): 1075-1084, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38265747
2.
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
N Engl J Med
; 381(16): 1535-1546, 2019 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562797
3.
Overall survival in the real-world and clinical trials: a case study validating external controls in advanced melanoma.
Future Oncol
; 18(11): 1321-1331, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35048743
4.
Comparative efficacy and safety of adjuvant nivolumab versus other treatments in adults with resected melanoma: a systematic literature review and network meta-analysis.
BMC Cancer
; 21(1): 3, 2021 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33402121
5.
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
BMC Cancer
; 21(1): 642, 2021 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34051732
6.
Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.
Cancer Med
; 12(3): 2378-2388, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880244
7.
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial.
Eur J Cancer
; 187: 164-173, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37167764
8.
Cost-Utility of Nivolumab Plus Ipilimumab in First-Line Treatment of Advanced Melanoma in the United States: An Analysis Using Long-Term Overall Survival Data from Checkmate 067.
Pharmacoecon Open
; 6(5): 697-710, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006606
9.
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.
MDM Policy Pract
; 7(1): 23814683221089659, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356551
10.
Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma.
Eur J Cancer
; 158: 225-233, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663559
11.
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067.
J Immunother Cancer
; 9(11)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34799400
12.
Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France.
Dermatol Ther (Heidelb)
; 10(6): 1331-1343, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920709
13.
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors.
Eur J Cancer
; 137: 171-174, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777716
14.
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma.
Exp Hematol Oncol
; 8: 14, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31312536
15.
Integrating feedback from a clinical data warehouse into practice organisation.
Int J Med Inform
; 75(3-4): 232-9, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16153886
16.
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada.
J Med Econ
; 19(6): 557-67, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26761644
17.
When is bioavailable testosterone a redundant test in the diagnosis of hypogonadism in men?
Clin Biochem
; 38(9): 813-8, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15961071
18.
Depression and mortality in the visually-impaired, community-dwelling, elderly population of Quebec.
Acta Ophthalmol
; 86(2): 196-201, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17888085
Resultados
1 -
18
de 18
1
Próxima >
>>